IbeR facilitates stress-resistance, invasion and pathogenicity of avian pathogenic Escherichia coli

PloS One
Shaohui WangChengping Lu

Abstract

Systemic infections by avian pathogenic Escherichia coli (APEC) are economically devastating to poultry industries worldwide. IbeR, located on genomic island GimA, was shown to serve as an RpoS-like regulator in rpoS gene mutation neonatal meningitis E. coli (NMEC) RS218. However, the role of IbeR in pathogenicity of APEC carrying active RpoS has not yet been investigated. We showed that the APEC IbeR could elicit antibodies in infected ducks, suggesting that IbeR might be involved in APEC pathogenicity. To investigate the function of IbeR in APEC pathogenesis, mutant and complementation strains were constructed and characterized. Inactivation of ibeR led to attenuated virulence and reduced invasion capacity towards DF-1 cells, brains and cerebrospinal fluid (CSF) in vitro and in vivo. Bactericidal assays demonstrated that the mutant strain had impaired resistance to environmental stress and specific pathogen-free (SPF) chicken serum. These virulence-related phenotypes were restored by genetic complementation. Quantitative real-time reverse transcription PCR revealed that IbeR controlled expression of stress-resistance genes and virulence genes, which might led to the associated virulence phenotype.

References

May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P DavanlooF W Studier
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Aug 14, 2001·Infection and Immunity·K S Kim
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 29, 2002·The Journal of Infectious Diseases·James R Johnson, Thomas A Russo
Sep 5, 2002·Research in Veterinary Science·R M La Ragione, M J Woodward
Nov 9, 2002·The Journal of Infectious Diseases·Kwang Sik Kim
Apr 9, 2005·Microbiology·Pierre GermonMaryvonne Moulin-Schouleur
Mar 22, 2007·International Journal of Medical Microbiology : IJMM·Christa EwersLothar H Wieler
May 9, 2012·Veterinary Microbiology·Shaohui WangChengping Lu
Jun 26, 2012·Journal of Bacteriology·Maud FléchardPierre Germon
Oct 11, 2012·Microbial Pathogenesis·Xiangan HanShengqing Yu

❮ Previous
Next ❯

Datasets Mentioned

BETA
JQ767181.1

Methods Mentioned

BETA
environmental stress
PCR
reverse transcription PCR

Software Mentioned

GraphPad

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.